Key result
Cholesterol crystal embolization is a systemic illness with frequent cutaneous manifestations, as well as common involvement of the renal and gastrointestinal systems.
This review provides a comprehensive overview of cholesterol crystal embolization, highlighting its systemic nature and frequent cutaneous manifestations.
Answers are grounded in this paper and cite their sources.
Cutaneous signs warrant systemic evaluation in at-risk patients; leaves open the need for prospective validation of management strategies.
In this paper the basic pathogenesis of cholesterol crystal embolization (CCE) is described, its clinical characteristics are presented and diagnosis and therapy are discussed. The main focus will be on the cutaneous manifestations; however, considering that CCE is a systemic illness, findings in other organs will also be highlighted, particularly the commonly involved renal and gastrointestinal systems.
No takes yet. Share an insight, caveat, or question.
Donohue et al. (2003) conducted a review in Cholesterol crystal embolization (CCE). Cholesterol crystal embolization is a systemic illness with frequent cutaneous manifestations, as well as common involvement of the renal and gastrointestinal systems.
Synapse has enriched 10 related papers. Consider them for comparative context: